FDA Approves New, Once-A-Day CFTR Modulator for People With CF
December 22, 2024
December 22, 2024
BETHESDA, Maryland, Dec. 22 -- Cystic Fibrosis Foundation issued the following news release:
* * *
A new CFTR modulator treatment called Alyftrek has been approved for people with CF ages 6 and older who have CFTR mutations that are eligible for Trikafta, as well as 31 other rare mutations that have not been approved previously for any other CFTR modulator.
* * *
The U.S. Food and Drug Administration (FDA) has approved the new triple-combinatio . . .
* * *
A new CFTR modulator treatment called Alyftrek has been approved for people with CF ages 6 and older who have CFTR mutations that are eligible for Trikafta, as well as 31 other rare mutations that have not been approved previously for any other CFTR modulator.
* * *
The U.S. Food and Drug Administration (FDA) has approved the new triple-combinatio . . .